Literature DB >> 7695285

Inhibition of hepatitis B virus in tissue culture by alpha interferon.

M G Davis1, R W Jansen.   

Abstract

Alpha-n1 interferon (Wellferon), alpha-2a interferon (Roferon), and alpha-2b interferon (Intron-A) inhibited accumulation of intracellular replicative forms of hepatitis B virus (HBV) in chronic producer cells by inhibiting accumulation of RNase-resistant HBV RNA. In contrast, the nucleoside analog FTC (cis-5-fluoro-1- [2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine) inhibited the accumulation of HBV DNA.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7695285      PMCID： PMC188309          DOI： 10.1128/AAC.38.12.2921

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

Review 1.  Interferon-induced proteins and the antiviral state.

Authors:  P Staeheli
Journal:  Adv Virus Res       Date:  1990       Impact factor: 9.937

Review 2.  Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities.

Authors:  C E Samuel
Journal:  Virology       Date:  1991-07       Impact factor: 3.616

3.  Mapping and expression of a human cytomegalovirus major viral protein.

Authors:  M G Davis; E C Mar; Y M Wu; E S Huang
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

4.  Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA.

Authors:  T Tsurimoto; A Fujiyama; K Matsubara
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

5.  Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

Authors:  M A Sells; M L Chen; G Acs
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

6.  Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues.

Authors:  S L Doong; C H Tsai; R F Schinazi; D C Liotta; Y C Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

7.  Type I interferons inhibit hepatitis B virus replication and induce hepatocellular gene expression in cultured liver cells.

Authors:  W H Caselmann; M Meyer; S Scholz; P H Hofschneider; R Koshy
Journal:  J Infect Dis       Date:  1992-11       Impact factor: 5.226

8.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen.

Authors:  B B Knowles; C C Howe; D P Aden
Journal:  Science       Date:  1980-07-25       Impact factor: 47.728

9.  High-capacity in vitro assessment of anti-hepatitis B virus compound selectivity by a virion-specific polymerase chain reaction assay.

Authors:  R W Jansen; L C Johnson; D R Averett
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

10.  A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA.

Authors:  M Junker-Niepmann; R Bartenschlager; H Schaller
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598
View more
  10 in total

Review 1.  Molecular virology of hepatitis B virus for clinicians.

Authors:  Timothy M Block; Haitao Guo; Ju-Tao Guo
Journal:  Clin Liver Dis       Date:  2007-11       Impact factor: 6.126

2.  Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication.

Authors:  S K Ladner; M J Otto; C S Barker; K Zaifert; G H Wang; J T Guo; C Seeger; R W King
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

Review 3.  Interferon-alpha-2b plus ribavirin: a review of its use in the management of chronic hepatitis C.

Authors:  Lesley J Scott; Caroline M Perry
Journal:  Drugs       Date:  2002       Impact factor: 9.546

4.  In vitro resistance to interferon of hepatitis B virus with precore mutation.

Authors:  Yan Wang; Lai Wei; Dong Jiang; Xu Cong; Ran Fei; Jiang Xiao; Yu Wang
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

5.  1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity.

Authors:  S M Daluge; S S Good; M B Faletto; W H Miller; M H St Clair; L R Boone; M Tisdale; N R Parry; J E Reardon; R E Dornsife; D R Averett; T A Krenitsky
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

6.  Elimination of duck hepatitis B virus RNA-containing capsids in duck interferon-alpha-treated hepatocytes.

Authors:  U Schultz; J Summers; P Staeheli; F V Chisari
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

7.  Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein.

Authors:  E Gordien; O Rosmorduc; C Peltekian; F Garreau; C Bréchot; D Kremsdorf
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

8.  Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures.

Authors:  Valérie Pasquetto; Stefan F Wieland; Susan L Uprichard; Marco Tripodi; Francis V Chisari
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

9.  Effect of oral administration of emtricitabine on woodchuck hepatitis virus replication in chronically infected woodchucks.

Authors:  B E Korba; R F Schinazi; P Cote; B C Tennant; J L Gerin
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

10.  Chinese herbal medicine and interferon in the treatment of chronic hepatitis B: a meta-analysis of randomized, controlled trials.

Authors:  Michael McCulloch; Michael Broffman; Jin Gao; John M Colford
Journal:  Am J Public Health       Date:  2002-10       Impact factor: 9.308
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.